Page 59 - BH-2-4

Brain & Heart Stem cells in cardiovascular disease

doi: 10.1136/openhrt-2021-001658 Acta Biomater. 2024;180:61-81.
4. Zhang Y, Mignone J, MacLellan WR. Cardiac regeneration doi: 10.1016/j.actbio.2024.04.008
and stem cells. Physiol Rev. 2015;95(4):1189-1204.
16. Liu W, Zhang X, Jiang X, et al. Decellularized extracellular
doi: 10.1152/physrev.00021.2014 matrix materials for treatment of ischemic cardiomyopathy.
Bioact Mater. 2024;33:460-482.
5. Yoshida Y, Yamanaka S. Induced pluripotent stem
cells 10 years later: For cardiac applications. Circ Res. doi: 10.1016/j.bioactmat.2023.10.015
2017;120(12):1958-1968.
17. Prat-Vidal C, Rodríguez-Gómez L, Aylagas M, et al. First-
doi: 10.1016/j.ijsu.2013.05.037 in-human PeriCord cardiac bioimplant: Scalability and
6. Escribá R, Larrañaga-Moreira JM, Richaud-Patin Y, et al. GMP manufacturing of an allogeneic engineered tissue
iPSC-based modeling of variable clinical presentation in graft. EBioMedicine. 2020;54:102729.
hypertrophic cardiomyopathy. Circ Res. 2023;133(2):108-119. doi: 10.1016/j.ebiom.2020.102729
doi: 10.1161/CIRCRESAHA.122.321951 18. Sun X, Wu J, Qiang B, et al. Transplanted microvessels
7. Bryl R, Kulus M, Bryja A, et al. Cardiac progenitor cell improve pluripotent stem cell-derived cardiomyocyte
therapy: Mechanisms of action. Cell Biosci. 2024;14:30. engraftment and cardiac function after infarction in rats. Sci
Transl Med. 2020;12(562):eaax2992.
doi: 10.1186/s13578-024-01211-x
doi: 10.1126/scitranslmed.aax2992
8. Natsumeda M, Suncion V, Balkan W, Hare J. The impact of
intramyocardial mesenchymal stem cell injection according 19. Saeed S, Khan SU, Khan WU, et al. Genome editing
to scar size for the treatment of ischemic cardiomyopathy. technology: A new frontier for the treatment and
J Am Coll Cardiol. 2016;67(13 Supplement):158-158. prevention of cardiovascular diseases. Curr Probl Cardiol.
2023;48(7):101692.
doi: 10.1016/S0735-1097(16)30159-0
doi: 10.1016/j.cpcardiol.2023.101692
9. Bartunek J, Wojakowski W. Intracoronary autologous bone
marrow cell transfer after acute myocardial infarction: Abort 20. Schary Y, Rotem I, Caller T, et al. CRISPR-Cas9 editing of
and refocus. Eur Heart J. 2017;38(39):2944-2947. TLR4 to improve the outcome of cardiac cell therapy. Sci
Rep. 2023;13(1):4481.
doi: 10.1093/eurheartj/ehx300
doi: 10.1038/s41598-023-31286-4
10. Povsic TJ. Emerging therapies for congestive heart failure.
Clin Pharmacol Ther. 2018;103(1):77-87. 21. Bao X, Liang Y, Chang H, et al. Targeting proprotein
convertase subtilisin/kexin type 9 (PCSK9): From bench to
doi: 10.1002/cpt.913 bedside. Signal Transduct Target Ther. 2024;9(1):13.
11. Correia CD, Ferreira A, Fernandes MT, et al. Human stem doi: 10.1038/s41392-023-01690-3
cells for cardiac disease modeling and preclinical and
clinical applications-are we on the road to success? Cells. 22. Bakinowska E, Kiełbowski K, Boboryko D, et al. The role of
2023;12(13):1727. stem cells in the treatment of cardiovascular diseases. Int J
Mol Sci. 2024;25(7):3901.
doi: 10.3390/cells12131727
doi: 10.3390/ijms25073901
12. Clinical Trials, National Library of Medicine (National
Center for Biotechnology Information. Available from: 23. Chamuleau SA, van Belle E, Doevendans PA. Enhancing
https://clinicaltrials.gov [Last accessed on 2024 Oct 17]. cardiac stem cell differentiation into cardiomyocytes.
Cardiovasc Res. 2009;82(3):385-387.
13. Ratajczak MZ, Ratajczak J, Kucia M. Very small embryonic-
like stem cells (VSELs) – an update and future directions. doi: 10.1093/cvr/cvp114
Circ Res. 2019;124(2):208-210.
24. Wu R, Hu X, Wang J. Concise review: Optimized strategies
doi: 10.1161/CIRCRESAHA.118.314287 for stem cell-based therapy in myocardial repair: Clinical
translatability and potential limitation. Stem Cells.
14. Gounari E, Daniilidis A, Tsagias N, et al. Isolation of a novel 2018;36(4):482-500.
embryonic stem cell cord blood–derived population with
in vitro hematopoietic capacity in the presence of Wharton’s doi: 10.1002/stem.2778
jelly-derived mesenchymal stromal cells. Cytotherapy. 25. Olatunji G, Kokori E, Yusuf I, et al. Stem cell-based
2019;21(2):246-259.
therapies for heart failure management: A narrative review
doi: 10.1016/j.jcyt.2018.11.006 of current evidence and future perspectives. Heart Fail Rev.
2024;29(3):573-598.
15. Sedláková V, Mourcos S, Pupkaitė J, et al. Biomaterials for
direct cardiac repair-A rapid scoping review 2012-2022. doi: 10.1007/s10741-023-10351-0

Volume 2 Issue 4 (2024) 9 doi: 10.36922/bh.4521